Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.09B P/E - EPS this Y 9.60% Ern Qtrly Grth -
Income -31.75M Forward P/E 18.30 EPS next Y 9.80% 50D Avg Chg 14.00%
Sales 1.19B PEG -4.46 EPS past 5Y 0.02% 200D Avg Chg 15.00%
Dividend N/A Price/Book 2.49 EPS next 5Y -4.60% 52W High Chg -14.00%
Recommedations 2.00 Quick Ratio 1.58 Shares Outstanding 54.15M 52W Low Chg 43.00%
Insider Own 0.50% ROA 2.31% Shares Float 51.09M Beta 0.94
Inst Own 105.63% ROE -2.59% Shares Shorted/Prior 3.09M/3.49M Price 57.46
Gross Margin 67.93% Profit Margin -2.68% Avg. Volume 407,064 Target Price 71.00
Oper. Margin 8.55% Earnings Date Jul 24 Volume 231,748 Change -1.88%
About LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LivaNova PLC News
05/03/24 LivaNova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
05/02/24 LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript
05/01/24 LivaNova PLC (LIVN) Surpasses Analyst Revenue Forecasts in Q1 2024
05/01/24 LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates
05/01/24 LivaNova Reports First-Quarter 2024 Results
04/30/24 LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
04/26/24 Livanova says patient data obtained in 2023 cyberattack
04/26/24 LivaNova gives notice of personal patient data compromised by hackers
04/25/24 LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
04/25/24 Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
04/24/24 LivaNova (LIVN) Earnings Expected to Grow: Should You Buy?
04/15/24 Shareholders in LivaNova (NASDAQ:LIVN) have lost 34%, as stock drops 3.1% this past week
03/21/24 LivaNova to Announce First-Quarter 2024 Results
03/21/24 LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
03/20/24 LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
03/19/24 Returns On Capital Signal Difficult Times Ahead For LivaNova (NASDAQ:LIVN)
03/05/24 LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
04:44 PM LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
09:00 AM LivaNova to Present at the Barclays Global Healthcare Conference
02/23/24 Has LivaNova PLC's (NASDAQ:LIVN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
LIVN Chatroom

User Image Following_the_trend Posted - 2 days ago

$LIVN Been buying small increments since December. Looks like this one will pay me well. Hope to see upper seventies or low eighties.

User Image contangoz Posted - 3 days ago

took $isrg profits into $livn pstn

User Image contangoz Posted - 3 days ago

added to watchlist - heavy accumulation $livn

User Image Doozio Posted - 3 days ago

Chop chop huckleberries n yo $livn on 🧠⏰

User Image DonCorleone77 Posted - 3 days ago

$LIVN LivaNova raises FY24 adjusted EPS view to $3.05-$3.15 from $2.95-$3.05 Consensus for FY24 EPS is $3.00. Raises FY24 revenue growth view to up 6%-7% from up 4%-5% on a constant-currency basis, consensus $1.21B. When excluding the impact of the ACS segment wind down, the company now expects revenue for FY24 to grow 8%-9% from 6%-7% on a constant-currency basis.

User Image DonCorleone77 Posted - 3 days ago

$LIVN LivaNova reports Q1 adjusted EPS 73c, consensus 49c Reports Q1 revenue $294.9M, consensus $278.66M. "In Q1, LivaNova achieved double-digit revenue and operating income growth in both the Cardiopulmonary and Neuromodulation segments," said CEO Vladimir Makatsaria. "I am grateful to our teams around the world for their exceptional work and dedication to serving our patients and customers. Looking ahead, our priorities continue to emphasize execution, innovation and talent development. We are confident that by delivering in each of these areas, we will improve patient outcomes and create shareholder value."

User Image epsguid Posted - 3 days ago

$LIVN reported earnings of $0.73, consensus was $0.45 via @eWhispers #epsbeat http://eps.sh/d/livn

User Image Stock_Titan Posted - 3 days ago

$LIVN LivaNova Reports First-Quarter 2024 Results https://www.stocktitan.net/news/LIVN/liva-nova-reports-first-quarter-2024-2cuougtsb1yp.html

User Image Stock_Titan Posted - 04/30/24

$LIVN LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer https://www.stocktitan.net/news/LIVN/liva-nova-announces-ahmet-tezel-ph-d-as-chief-innovation-i83qfrgoriqn.html

User Image Stock_Titan Posted - 04/25/24

$LIVN LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident https://www.stocktitan.net/news/LIVN/liva-nova-issues-notice-to-u-s-patients-regarding-cybersecurity-xrwrpg27bps2.html

User Image Fullratio Posted - 04/22/24

Healthcare sector stocks with high EPS growth in Q4 2023 (TTM): $LIVN $PBYI $RPRX

User Image StockInvest_us Posted - 04/18/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/B2JhJM8LnD

User Image StockInvest_us Posted - 04/16/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/onGyobZSkO

User Image StockInvest_us Posted - 04/10/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/WvHcIWKXbJ

User Image BmanCCP Posted - 04/05/24

@4WVUinKY The ART100 while FDA approval will be great it’s still only the hardware. Hospitals have the hardware currently. They need disposable. VORTX and HYLA are what will make the money. Capital Equip is replaced average 10+ years. Disposables are needed daily. That will be the real catalyst and profitability. $LIVN just shelved their ECMO device and entire MCS portfolio. https://investor.livanova.com/news-releases/news-release-details/livanova-wind-down-advanced-circulatory-support-business-unit

User Image StockInvest_us Posted - 04/05/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/UkVbY8ZFhK

User Image StockInvest_us Posted - 1 month ago

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/gIjK9v9v2n

User Image StockInvest_us Posted - 03/28/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/TOTg02typ0

User Image Stock_Titan Posted - 03/21/24

$LIVN LivaNova to Announce First-Quarter 2024 Results https://www.stocktitan.net/news/LIVN/liva-nova-to-announce-first-quarter-2024-ok6orzv1s51a.html

User Image healthcareguru Posted - 03/20/24

@stocksguru1974 Nyxoah & $LIVN competitive data both out today/last night.

User Image _StockTrader Posted - 03/20/24

Real-Time Stock Data $LIVN Price: 55.74 Volume: 1250795 Market Cap: 2997806592 PE Ratio: 16.73494 Powered by: OZSC

User Image tradingtwenty Posted - 03/20/24

$LIVN has trended 5 times in the past 24 hours (based on 5 minute intervals). Latest press release on Mar 20, 2024 09:00 AM: LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe... Link: https://tradingtwenty.com/news/400781/livanova-announces-a-positive-predictive-outcome-of-trial-success-in-its-osprey-clinical-study-for-moderate-to-severe-obstructive-sleep-apnea

User Image TheTradeXchange Posted - 03/20/24

$LIVN LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

User Image Stock_Titan Posted - 03/20/24

$LIVN LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea https://www.stocktitan.net/news/LIVN/liva-nova-announces-a-positive-predictive-outcome-of-trial-success-okp1w8h5nde5.html

User Image StockInvest_us Posted - 03/20/24

Signal alert: $LIVN - GoldenStar https://stockinvest.us/l/t0k6i6pRIv

User Image StockInvest_us Posted - 03/14/24

Signal alert: $LIVN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/39uLwHWBmI

User Image BmanCCP Posted - 03/12/24

If VORTX Oxy Tech translates into clinical use this company will rival cardiopulmonary units of $LIVN $MDT

User Image Stock_Titan Posted - 03/05/24

$LIVN LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029 https://www.stocktitan.net/news/LIVN/liva-nova-announces-pricing-of-private-offering-of-300-million-of-2-57ksp7gao0sd.html

User Image DonCorleone77 Posted - 1 month ago

$LIVN LivaNova announces proposed offering of $300M of convertible senior notes LivaNova "announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, subject to market conditions and other factors. LivaNova also intends to grant to the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $45 million aggregate principal amount of the notes."

User Image Stock_Titan Posted - 1 month ago

$LIVN LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes https://www.stocktitan.net/news/LIVN/liva-nova-announces-proposed-private-offering-of-300-million-of-477xwb27a0xk.html

Analyst Ratings
Mizuho Buy May 2, 24
Baird Neutral May 2, 24
Needham Buy May 1, 24
Mizuho Buy Mar 27, 24
Needham Buy Mar 20, 24
Barclays Equal-Weight Feb 27, 24
Barclays Equal-Weight Feb 26, 24
Baird Neutral Feb 22, 24
Mizuho Buy Feb 22, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Moore Daniel Jeffrey Director Director Apr 01 Sell 83.416 1,000 83,416 24,630 04/05/22
Shvartsburg Alex CFO CFO Mar 30 Option 20.38 2,352 47,934 5,425 04/01/22
McDonald Damien CEO CEO Mar 29 Option 0 16,940 88,376 03/31/22
McDonald Damien CEO CEO Mar 29 Sell 81.5 2,784 226,896 76,993 03/31/22
Moore Daniel Jeffrey Director Director Mar 02 Sell 80 1,000 80,000 25,630 03/03/22
Moore Daniel Jeffrey Director Director Feb 25 Sell 80 1,000 80,000 26,630 03/01/22
Novak Alfred J Director Director Nov 10 Sell 89.97 2,981 268,201 11,368 11/12/21
Dolci Marco SVP Global Operation.. SVP Global Operations, R&D May 20 Option 43.57 3,926 171,056 3,926 05/20/21
Dolci Marco SVP Global Operation.. SVP Global Operations, R&D May 20 Sell 83.05 8,278 687,488 05/20/21